We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Alisa
Mohamed Azhar
aazhar@sgul.ac.uk
Alisa
Mohamed Azhar
aazhar@sgul.ac.uk
Prof
Pippa
Oakeshott
oakeshot@sgul.ac.uk
Dr
Asma
Khalil
akhalil@sgul.ac.uk
Other infectious diseasesPersons encountering health services in circumstances related to reproduction
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background
Vaccinations against whooping cough/pertussis, flu and other infections like Covid-19 and RSV can protect pregnant women/people and their babies from disease or death. But many pregnant women miss out on these vaccinations, especially women living in more deprived parts of the country.
To find out why vaccination rates are low we reviewed existing research. We also did two studies in socially and ethnically mixed areas of London and asked pregnant women/people and health providers for their recommendations.
Our goal is to increase informed choice and uptake of recommended vaccinations during pregnancy to improve health. First, we will carry out development work in London and Liverpool.
Proposed development work over 14 months
We will interview 10-15 midwives. Then with pregnant women, midwives and others we will develop an improvement programme to increase vaccine uptake in pregnancy.
This will focus on: service users, providers and services.
• For service users
We will develop brief videos, where ‘real’ people, including midwives and pregnant women/people and their families, share their personal stories about vaccinations in pregnancy.
• For providers
We will develop materials and training for midwives to increase their knowledge and confidence in maternal vaccines and help them advise pregnant women/people about vaccinations during pregnancy. To do this we will use evidence on how and why people change what they do to improve their health.
• Services
We will explore possible organisational and systemic changes to improve vaccination rates.
We will then gain feedback about our programme from 20 women and 20 midwives and adapt if needed.
Patient and public involvement:
Pregnant women/people helped design the research. We will work with them at every step, from designing the programme and research to sharing the results.
Expected impacts:
If our programme is acceptable, we will apply for funding to see if it increases vaccination rates.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
- Does not fulfil inclusion criteria for any of the participant groups above - Anyone who is not capable of understanding the study and thus providing informed consent - Anyone who does not provide (written or oral) informed consent In the final interview study with pregnant women who have been offered our co-developed vaccine promotion intervention, we will not recruit anyone who has already received all recommended maternal vaccines. This is because we want to focus on women who have reservations about being vaccinated.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Alisa
Mohamed Azhar
aazhar@sgul.ac.uk
Prof
Pippa
Oakeshott
oakeshot@sgul.ac.uk
Dr
Asma
Khalil
akhalil@sgul.ac.uk
Alisa
Mohamed Azhar
aazhar@sgul.ac.uk
The study is sponsored by ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 58387
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
